Parkinson Disease: all 4,583 studies
Page 42 of 46. Open to participants first (1,097), then studies with results posted, then the rest; newest registration first within each.
- Parkinson's Disease, Diagnostic Observations (PADDO)Status unknownNCT01249768
- Sensory Attention Focused Exercise in Parkinson's DiseaseStatus unknownNCT01246700Not applicable
- Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled BreathCompletedNCT01246336
- The Effect of Methylphenidate on Non-motor Symptoms and Postural Control in Parkinson's Disease.TerminatedNCT01244269Phase 4
- Vitamin B6, B12, Folic Acid and Exercise in Parkinson's DiseaseStatus unknownNCT01238926Not applicable
- 7T MRS in Parkinson's DiseaseCompletedNCT01237210
- Feasibility Study to Evaluate Deep Brain Stimulation (DBS) Settings for the Treatment of Parkinson's DiseaseWithdrawnNCT01230151Not applicable
- A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease PatientsCompletedNCT01229332Phase 1/2
- Balance Training in Parkinson's Disease Using the Wii Balance BoardCompletedNCT01228851Not applicable
- Biofeedback-based Motor Learning to Ameliorate Freezing of GaitStatus unknownNCT01223781Not applicable
- Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD StudyWithdrawnNCT01218919
- Nicotine Treatment of Impulsivity in Parkinson's DiseaseStatus unknownNCT01216904Phase 4
- A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's DiseaseCompletedNCT01211587Phase 2
- Physiological Brain Atlas DevelopmentCompletedNCT01210534
- Evaluation of a Diet in Patients With Senile DementiaStatus unknownNCT01192529Not applicable
- Caffeine for Motor Manifestations of Parkinson's DiseaseCompletedNCT01190735Phase 2
- Pilot Study of Maintenance Therapy With Intravenous AMANTADINEStatus unknownNCT01190553Not applicable
- Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's DiseaseCompletedNCT01187966Phase 3
- Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's DiseaseTerminatedNCT01178047Phase 4
- Glutathione (GSH) In The Treatment of Parkinson's DiseaseCompletedNCT01177319Phase 2
- Exendin-4 as a Treatment for Parkinson's Disease - Pilot StudyStatus unknownNCT01174810Phase 2
- Development of an Instrumented System to Measure Mobility in Parkinson's DiseaseCompletedNCT01174758
- Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasCompletedNCT01173731Phase 2
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period DyskinesiasCompletedNCT01172379Phase 2
- A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease SubjectsCompletedNCT01171313Phase 2
- Effect of Deep Brain Stimulation (DBS) on Sleep Architecture in Patients With Movement DisordersCompletedNCT01169324Not applicable
- Dance Exercise as Novel Complementary Therapy for Parkinson's DiseaseCompletedNCT01163344
- Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing Therapy for PD-related Voice/Speech ImpairmentCompletedNCT01163331Not applicable
- Computer-Based Balance Training for People With Parkinson's DiseaseCompletedNCT01162226Phase 2
- Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's DiseaseCompletedNCT01155492
- Brain Fitness in Parkinson's DiseaseCompletedNCT01155349Phase 3
- Relaxation Guided Imagery for Treatment of Parkinson's DiseaseCompletedNCT01151111Early Phase 1
- A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's DiseaseCompletedNCT01149811
- Phosphorylation of ERK1/2 in Patients With Parkinson's DiseaseCompletedNCT01142739
- Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease ProgressionCompletedNCT01141023Phase 2
- A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving LevodopaCompletedNCT01140841
- Visual Selective Attention in Parkinson's DiseaseCompletedNCT01135407
- Computer-based Cognitive Training for Parkinson DiseaseCompletedNCT01121627Not applicable
- Virtual Reality in Motor Performance and Quality of Life in Patients With Parkinson's DiseaseCompletedNCT01120392Phase 2/3
- Glucose Tolerance in Patients With an Idiopathic Parkinson's DiseaseStatus unknownNCT01114321Not applicable
- Study of Subthalamic Brain Stimulation in Parkinson Disease (PD)CompletedNCT01113684
- Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease SubjectsCompletedNCT01113320Phase 2
- Use of Noninvasive Brain Stimulation in Parkinson's DiseaseCompletedNCT01113086Not applicable
- Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's DiseaseCompletedNCT01108029Phase 4
- Genetics of Motor LearningTerminatedNCT01105845
- Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611CompletedNCT01103011Phase 1
- An Observational Study for the Prevalence of Neuropsychiatric Symptom in Parkinson's Disease DementiaCompletedNCT01102582
- Deep Brain Stimulation Effects StudyTerminatedNCT01098565Phase 1
- Rasagiline for Gait TreatmentStatus unknownNCT01098396
- Italian Validation of the Revised MDS-Unified Parkinson's Disease Rating ScaleStatus unknownNCT01092936
- Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced DyskinesiaCompletedNCT01092065Phase 2
- Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic CharacteristicsStatus unknownNCT01089283
- Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree RelativesStatus unknownNCT01089270
- Nucleipark:High Field MR Imaging (7T and 3T) of the Brainstem, the Deep Nuclei and Their Connections in the Parkinsonian Syndromes. Applications to Prognosis, Pathophysiology and Improvement of Therapeutic StrategiesCompletedNCT01085253
- Clinical, Molecular and by Neuroimaging of LRRK2 MutationsCompletedNCT01085227
- Effect of Deep Brain Stimulation on Gastrointestinal (GI) MotilityCompletedNCT01081457Not applicable
- Effectiveness of Physiotherapy Interventions for Patients With Parkinson's DiseaseStatus unknownNCT01076712Not applicable
- The Influence of Sensory Stimuli on Gait Imagery in Patients With Freezing of GaitCompletedNCT01071590
- Levodopa Concentration Profile With Stalevo 75/125 mgCompletedNCT01070628Phase 1
- Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's DiseaseCompletedNCT01066442Phase 3
- Extended Long-Term Safety Study of KW-6500CompletedNCT01063621Phase 3
- Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)CompletedNCT01060878Phase 2
- Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500CompletedNCT01058291Phase 3
- Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOnCompletedNCT01055379Phase 4
- PET Imaging in Parkinson Disease DementiaActive, not recruitingNCT01052350
- Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's DiseaseTerminatedNCT01048229Phase 4
- Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) StudyCompletedNCT01044992Not applicable
- White Matter Pathology in Parkinson's Disease (PD)Status unknownNCT01039831
- Efficacy of Continuous Apomorphine Infusion on Cognitive and Neuropsychological Functions in Parkinson's DiseaseCompletedNCT01039090Phase 3
- Prognostic Value of FP-CIT-SPECT in Parkinson´s DiseaseCompletedNCT01038310
- The Effect of Electrode Implantation for Deep Brain Stimulation (DBS) on Brain Function Using Single Photon Emission Computed Tomography (SPECT) With Technetium-99m-ethyl Cysteinatedimer (Tc-ECD)Status unknownNCT01037686Not applicable
- Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's DiseaseCompletedNCT01036139Phase 3
- Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's DiseaseCompletedNCT01032486
- MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918)TerminatedNCT01028586Phase 3
- Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological ConditionsTerminatedNCT01028209Phase 1
- A Study to Assess the Effect of Safinamide on Levodopa PharmacokineticsCompletedNCT01026428Phase 1/2
- Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease PatientsCompletedNCT01023282Phase 1
- Apathy in Parkinson Disease: Clinical, Physiopathological and Pharmacological StudyStatus unknownNCT01020682
- Physiological Investigations of Movement DisordersCompletedNCT01019343Not applicable
- Efficacy of Nutritional Supplement VIUSID/ALZER in Patients With Parkinson's DiseaseCompletedNCT01016470Phase 3
- Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's DiseaseTerminatedNCT01014858Phase 3
- Non-contact Boxing Training and Traditional Therapeutic Exercise for Persons With Parkinson's DiseaseCompletedNCT01014663Not applicable
- Safety Study of Erythropoietin (EPO) in Parkinson's DiseaseCompletedNCT01010802Phase 1
- Feasibility of a Trial Evaluating the Effectiveness of Occupational Therapy in Parkinson's DiseaseCompletedNCT01010529Not applicable
- Retinal Function in Parkinson's DiseaseStatus unknownNCT01010074
- Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine AgonistsCompletedNCT01007864Phase 3
- A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's PatientsStatus unknownNCT01007630Phase 4
- Spectroscopy in Parkinson DiseaseStatus unknownNCT01005030
- Quantification of Cerebral Cholinergic Function in Parkinson´s Disease by Means of Nuclear Medicine MethodsCompletedNCT01003535
- Natural History of Levodopa-Induced Dyskinesia (LID)WithdrawnNCT01003002
- Shanghai Parkinson's StudyCompletedNCT00999388
- Using Heavy Water to Study Cell Dynamics in Parkinson's DiseaseStatus unknownNCT00990379
- Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's DiseaseCompletedNCT00986414Phase 2
- The Effects of Treadmill Versus Agility Training in Parkinson's DiseaseCompletedNCT00982709Not applicable
- Autologous Mesenchymal Stem Cell Transplant for Parkinson's DiseaseTerminatedNCT00976430Not applicable
- Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological ConditionsCompletedNCT00970333Phase 1
- Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.CompletedNCT00970229Phase 1
- Treadmill Training With Additional Body Load: Effects on Gait of Subjects With Parkinson´s DiseaseCompletedNCT00964652Not applicable
- Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa TherapyCompletedNCT00957918Phase 1/2
- Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease PatientsCompletedNCT00957203Phase 3